Back to News

Dr JF Prost joins Mabqi leadership team as new Medical Director

Mabqi is  thrilled to welcome Jean-François Prost, MD, as Acting Medical Director.

With over 30 years of top management experience in leading pharmaceutical companies (Servier, Pierre Fabre, UCB Pharma, LFB…), Jean-François brings a wealth of expertise in drug development and regulatory strategy. 

Through strategic leadership and scientific expertise, he played a pivotal role in securing five European Medicines Agency (EMA) approvals and four U.S. Food and Drug Administration (FDA) approvals. These achievements underscore his significant contribution to advancing medical innovation and expanding patient access to cutting-edge therapeutic treatments.

His arrival is an important step in strengthening our medical and scientific leadership team. We look forward to his commitment to pushing forward our portfolio of innovative antibodies in oncology. More particularly our 2 most advanced programs, MQI-191 & MQI-201, entering CMC in 2025.

Back to News